Výsledky vyhledávání - "Gregory P Wedin"

Impact of the extended-release/long-acting opioid analgesics risk evaluation and mitigation strategy on prescribing practices

Autor: Matthew H. Secrest, MSc, Syd Phillips, MPH, M. Soledad Cepeda, MD, PhD, David M. Kern, MS, PhD, Daina B. Esposito, MPH, PhD, Gregory P. Wedin, PharmD

Publikováno v: Journal of Opioid Management. 19:99-110

Objective: To assess the impact of extended-release (ER)/long-acting (LA) opioid prescriber training on prescribing behaviors.Design: Retrospective cohort study.Setting: Prescriber training was evaluated from June 1, 2013 through December 31, 2016. T

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9836540f6f44dbf8ce1af6c295a4ddab
https://doi.org/10.5055/jom.2023.0764

Zobrazit plný text záznamu

Appendix: Impact of the extended-release/long-acting opioid analgesics risk evaluation and mitigation strategy on prescribing practices - Appendix

Autor: Matthew H. Secrest, MSc, Syd Phillips, MPH, M. Soledad Cepeda, MD, PhD, David M. Kern, MS, PhD, Daina B. Esposito, MPH, PhD, Gregory P. Wedin, PharmD

Publikováno v: Journal of Opioid Management. 19:A1-A40

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::780e1b9f227d12dfb35d9b3eb0becc63
https://doi.org/10.5055/jom.2023.0764-appendix

Zobrazit plný text záznamu

Patient Knowledge of Safe Use of ER/LA Opioid Analgesics Following Implementation of the Class-Wide REMS: A Survey Study

Autor: Stephan Lanes, Crystal N. Holick, Vibha C. A. Desai, Judith J. Stephenson, Gregory P Wedin, M. Soledad Cepeda, Jennifer G Lyons, Daina B. Esposito

Publikováno v: Patient preference and adherence

Daina B Esposito,1 Vibha CA Desai,1 Judith J Stephenson,1 M Soledad Cepeda,2 Jennifer G Lyons,1 Crystal N Holick,1 Gregory P Wedin,3 Stephan Lanes1 On behalf of members of the REMS Program Companies Metrics Subteam1HealthCore, Inc., Wilmington, DE, U

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd0a54c65cfe9d9e4ed99efb4cd18b8b
http://europepmc.org/articles/PMC7917306

Zobrazit plný text záznamu

An Examination of State and Federal Opioid Analgesic and Continuing Education Policies: 2016–2018

Autor: Robert K. Twillman, Gregory P Wedin, David M. Kern, Stephen J. Ziegler, M. Soledad Cepeda, Kathryn N. Duensing, Maribel Salas

Publikováno v: Journal of Pain Research. 13:2431-2442

Introduction Opioid overdose deaths in the United States have climbed sharply over the past two decades. Simultaneously, increased awareness of inadequately treated chronic pain has resulted in increased opioid analgesic prescribing. The correlation

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a229742d77a31253163bd7554d9f8c04
https://doi.org/10.2147/jpr.s267448

Zobrazit plný text záznamu

Incidence of Opioid Overdose Among Patients Using ER/LA Opioid Analgesics Before and After Implementation of the Class-Wide Opioid Risk Evaluation and Mitigation Strategy

Autor: Crystal N. Holick, Shiva-Krishna Vojjala, Daina B. Esposito, Caitlin Knox, M. Soledad Cepeda, Stephan Lanes, Nianya Liu, Vibha C. A. Desai, Gregory P Wedin, Jennifer G Lyons

Publikováno v: Journal of Pain Research

Daina B Esposito, 1 M Soledad Cepeda, 2 Crystal N Holick, 1 Caitlin Knox, 1 Vibha CA Desai, 1 Nianya Liu, 1 Shiva-Krishna Vojjala, 1 Jennifer G Lyons, 1 Gregory P Wedin, 3 Stephan Lanes 1 On Behalf of the REMS Program Companies Metrics Subteam 1Healt

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dd47d71a90ec2a92aff6e7acccac379
https://doi.org/10.2147/jpr.s219324

Zobrazit plný text záznamu

Changes in Mortality Involving Extended-Release and Long-Acting Opioids After Implementation of a Risk Evaluation and Mitigation Strategy

Autor: Travis Rosen, Joshua C. Black, M. Soledad Cepeda, Richard C. Dart, Gabrielle E. Bau, Gregory P Wedin, Jody L. Green

Publikováno v: Pain Medicine: The Official Journal of the American Academy of Pain Medicine

Objective To assess changes in mortality rates in extended-release and long-acting (ER/LA) opioid analgesics after the implementation of the Risk Evaluation and Mitigation Strategy (REMS). Setting All drug poisoning deaths in three states: Florida, O

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b2d460463c5c63ac75cf6200dfc03b1
https://doi.org/10.1093/pm/pnz031

Zobrazit plný text záznamu

Frequency of Early Refills for Opioids in the United States

Autor: Matthew H. Secrest, M. Soledad Cepeda, Syd Phillips, Gregory P Wedin, David M. Kern, Maribel Salas

Publikováno v: Pain Medicine: The Official Journal of the American Academy of Pain Medicine

Objective Refilling an opioid prescription early is an important risk factor of prescription opioid abuse and misuse; we aimed to understand the scope of this behavior. This study was conducted to quantify the prevalence and distribution of early ref

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7012bfac9b1714ecb619187f3f4e50d
https://pubmed.ncbi.nlm.nih.gov/32529224

Zobrazit plný text záznamu

ER/LA Opioid Analgesics REMS: Overview of Ongoing Assessments of Its Progress and Its Impact on Health Outcomes

Autor: Laura Wallace, Jean-Yves Maziere, M. Soledad Cepeda, Paul Coplan, Gregory P Wedin, Nathan W. Kopper

Publikováno v: Pain Medicine: The Official Journal of the American Academy of Pain Medicine

Objective. Opioid abuse is a serious public health concern. In response, the Food and Drug Administration (FDA) determined that a risk evaluation and mitigation strategy (REMS) for extended-release and long-acting (ER/LA) opioids was necessary to ens

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37dda6e242d2dc0dc3981bcc56f82683
http://europepmc.org/articles/PMC5283702

Zobrazit plný text záznamu

Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy

Autor: Richard C. Dart, Gregory P Wedin, Becki Bucher Bartelson, Jean-Yves Maziere, M. Soledad Cepeda, Paul Coplan, Jody L. Green, M. Claire Le Lait

Publikováno v: Pharmacoepidemiology and drug safety. 26(9)

Purpose An unintended consequence of extended-release (ER) and long-acting (LA) prescription opioids is that these formulations can be more attractive to abusers than immediate-release (IR) formulations. The US Food and Drug Administration recognized

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::610b5c6ab08936a5a9550d8c80af083b
https://pubmed.ncbi.nlm.nih.gov/28758289

Zobrazit plný text záznamu

The Clinical Development of γ-Hydroxybutyrate (GHB)

Autor: Lisa M. Ylitalo, Gregory P. Wedin, Carl S. Hornfeldt

Publikováno v: Current Drug Safety. 1:99-106

The discovery of gamma-hydroxybutyrate (GHB) over 40 years ago led to its immediate use as a general anesthetic agent. Subsequent research demonstrated that GHB is an endogenous compound in the mammalian brain and current research suggests that GHB i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::74c09d8753a02526d1a2eac9740b1d6d
https://doi.org/10.2174/157488606775252647

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání